The New Emerging Treatment Choice for Major Depressive Disorders: Digital Therapeutics

Overview

Journal Adv Exp Med Biol

Specialties Biology
General Medicine

Date 2024 Sep 11

PMID 39261436

Authors

Chul-Hyun Cho

Heon-Jeong Lee

Yong-Ku Kim

Affiliations

Soon will be listed here.

Abstract

The chapter provides an in-depth analysis of digital therapeutics (DTx) as a revolutionary approach to managing major depressive disorder (MDD). It discusses the evolution and definition of DTx, their application across various medical fields, regulatory considerations, and their benefits and limitations. This chapter extensively covers DTx for MDD, including smartphone applications, virtual reality interventions, cognitive-behavioral therapy (CBT) platforms, artificial intelligence (AI) and chatbot therapies, biofeedback, wearable technologies, and serious games. It evaluates the effectiveness of these digital interventions, comparing them with traditional treatments and examining patient perspectives, compliance, and engagement. The integration of DTx into clinical practice is also explored, along with the challenges and barriers to their adoption, such as technological limitations, data privacy concerns, ethical considerations, reimbursement issues, and the need for improved digital literacy. This chapter concludes by looking at the future direction of DTx in mental healthcare, emphasizing the need for personalized treatment plans, integration with emerging modalities, and the expansion of access to these innovative solutions globally.

References

Aapro M, Bossi P, Dasari A, Fallowfield L, Gascon P, Geller M . Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives. Support Care Cancer. 2020; 28(10):4589-4612. PMC: 7447627. DOI: 10.1007/s00520-020-05539-1. View

Abd-Alrazaq A, Al-Jafar E, Alajlani M, Toro C, Alhuwail D, Ahmed A . The Effectiveness of Serious Games for Alleviating Depression: Systematic Review and Meta-analysis. JMIR Serious Games. 2022; 10(1):e32331. PMC: 8800090. DOI: 10.2196/32331. View

Adu-Brimpong J, Pugh J, Darko D, Shieh L . Examining Diversity in Digital Therapeutics Clinical Trials: Descriptive Analysis. J Med Internet Res. 2023; 25:e37447. PMC: 10433021. DOI: 10.2196/37447. View

Ahern E, Kinsella S, Semkovska M . Clinical efficacy and economic evaluation of online cognitive behavioral therapy for major depressive disorder: a systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res. 2017; 18(1):25-41. DOI: 10.1080/14737167.2018.1407245. View

Alavi N, Stephenson C, Yang M, Kumar A, Shao Y, Miller S . Feasibility and Efficacy of Delivering Cognitive Behavioral Therapy Through an Online Psychotherapy Tool for Depression: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2021; 10(6):e27489. PMC: 8277395. DOI: 10.2196/27489. View

Alneyadi M, Drissi N, Almeqbaali M, Ouhbi S . Biofeedback-Based Connected Mental Health Interventions for Anxiety: Systematic Literature Review. JMIR Mhealth Uhealth. 2021; 9(4):e26038. PMC: 8103295. DOI: 10.2196/26038. View

Brunt T, Gale-Grant O . Telepsychiatry: what clinicians need to know about digital mental healthcare. BJPsych Adv. 2023; 29(4):230-238. PMC: 10374879. DOI: 10.1192/bja.2022.42. View

Cheng S, Chang C, Chang W, Wang H, Liang C, Kishimoto T . The now and future of ChatGPT and GPT in psychiatry. Psychiatry Clin Neurosci. 2023; 77(11):592-596. PMC: 10952959. DOI: 10.1111/pcn.13588. View

Cho C, Lee H . Could Digital Therapeutics be a Game Changer in Psychiatry?. Psychiatry Investig. 2019; 16(2):97-98. PMC: 6393746. DOI: 10.30773/pi.2019.01.20. View

10.

Cho C, Lee T, Kim M, In H, Kim L, Lee H . Mood Prediction of Patients With Mood Disorders by Machine Learning Using Passive Digital Phenotypes Based on the Circadian Rhythm: Prospective Observational Cohort Study. J Med Internet Res. 2019; 21(4):e11029. PMC: 6492069. DOI: 10.2196/11029. View

11.

Cho C, Lee T, Lee J, Seo J, Jee H, Son S . Effectiveness of a Smartphone App With a Wearable Activity Tracker in Preventing the Recurrence of Mood Disorders: Prospective Case-Control Study. JMIR Ment Health. 2020; 7(8):e21283. PMC: 7439135. DOI: 10.2196/21283. View

12.

Chun J, Kim H, Hur J, Jung D, Lee H, Pack S . Prediction of Specific Anxiety Symptoms and Virtual Reality Sickness Using In Situ Autonomic Physiological Signals During Virtual Reality Treatment in Patients With Social Anxiety Disorder: Mixed Methods Study. JMIR Serious Games. 2022; 10(3):e38284. PMC: 9526108. DOI: 10.2196/38284. View

13.

Cipriani A, Furukawa T, Salanti G, Chaimani A, Atkinson L, Ogawa Y . Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018; 391(10128):1357-1366. PMC: 5889788. DOI: 10.1016/S0140-6736(17)32802-7. View

14.

Dahlhausen F, Zinner M, Bieske L, Ehlers J, Boehme P, Fehring L . There's an app for that, but nobody's using it: Insights on improving patient access and adherence to digital therapeutics in Germany. Digit Health. 2022; 8:20552076221104672. PMC: 9260569. DOI: 10.1177/20552076221104672. View

15.

Firth J, Torous J, Nicholas J, Carney R, Rosenbaum S, Sarris J . Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord. 2017; 218:15-22. DOI: 10.1016/j.jad.2017.04.046. View

16.

Freeman D, Reeve S, Robinson A, Ehlers A, Clark D, Spanlang B . Virtual reality in the assessment, understanding, and treatment of mental health disorders. Psychol Med. 2017; 47(14):2393-2400. PMC: 5964457. DOI: 10.1017/S003329171700040X. View

17.

Garcia L, Birckhead B, Krishnamurthy P, Sackman J, Mackey I, Louis R . An 8-Week Self-Administered At-Home Behavioral Skills-Based Virtual Reality Program for Chronic Low Back Pain: Double-Blind, Randomized, Placebo-Controlled Trial Conducted During COVID-19. J Med Internet Res. 2021; 23(2):e26292. PMC: 7939946. DOI: 10.2196/26292. View

18.

Ghosh A, Agnihotri J, Bhalotia S, Sati B, Agarwal L, A A . Serious Games Based on Cognitive Bias Modification and Learned Helplessness Paradigms for the Treatment of Depression: Design and Acceptability Study. JMIR Serious Games. 2023; 11:e37105. PMC: 10193222. DOI: 10.2196/37105. View

19.

Gostin L . National health information privacy: regulations under the Health Insurance Portability and Accountability Act. JAMA. 2001; 285(23):3015-21. DOI: 10.1001/jama.285.23.3015. View

20.

Hayes S, Levin M, Plumb-Vilardaga J, Villatte J, Pistorello J . Acceptance and commitment therapy and contextual behavioral science: examining the progress of a distinctive model of behavioral and cognitive therapy. Behav Ther. 2013; 44(2):180-98. PMC: 3635495. DOI: 10.1016/j.beth.2009.08.002. View